Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Debt / NOTE 0.599% 8/0
-
Unit price / market price
-
$1.05
-
Total 13F principal
-
$424,192,588
-
Principal change
-
+$55,598,706
-
Total reported value
-
$444,431,842
-
Number of holders
-
52
-
Value change
-
+$57,268,058
-
Number of buys
-
19
-
Number of sells
-
23
Institutional Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 as of Q1 2020
As of 31 Mar 2020 BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 had 52 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $424,192,588 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included ADVENT CAPITAL MANAGEMENT /DE/, MACKAY SHIELDS LLC, Partner Fund Management, L.P., LAZARD ASSET MANAGEMENT LLC, Allianz Asset Management GmbH, SHENKMAN CAPITAL MANAGEMENT INC, MORGAN STANLEY, JPMORGAN CHASE & CO, BAKER BROS. ADVISORS LP, and STATE STREET CORP.
This table shows 52 bond principal holders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.